Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just pick an exit point not around a conference call...
Another plus to the CC was that there was interest from some analyst from Bloomberg which was more than the last call. Hopefully all of his friends buy some shares.
The reason that people on the board get negative is this company has a history of always moving the finish line. I agree that there is new management and Mcnally did not waste the first five years of people's money however as an investor for many years there was that hope that this would be the year we got at least a field goal.
McNally spoke about upgrade to nasdaq but did not mention RS or time frame of uplisting.
Hopefully get some interest from investment houses that steer non institutional investors to Titan.
No party in Las vegas during 2018 maybe 2020
they just cut my call off!!!
Price drop was due to one large lot of shares sold and of course there is not much of a bid so the price dropped to 30 cents quickly but all of the shares were bought and the price back up to 32 cents because not many shares are being sold.
If you want to get out of a large position in this stock without positive news you will take a hit.
This is exactly what everyone on this board wanted an update and news to move the stock. It has been about 3 months since the last raise. If management has made significant progress over the holiday season and the first month of the year it will go a long way to solidify confidence in the company and should drive share price higher prior to fda submission.
I am shining my crystal ball.
I still own 500000 shares
Most of the work between those two centers, NYC will get more involved end of 1st quarter to beginning of 2nd quarter. I believe with only 10 employees working for Titan and having 3 centers they are concentrating efforts where making more progress but NYC will contribute. My opinion is that Titan employees have to be very efficient to get all of the data collected with only a small staff. If they meet their 1st quarter milestones will be a great team effort and I will be quite impressed. Lets see?
Lets talk about some about some relevant information. Physician contacts say that there is a lot of progress at the Florida and Europe location which will meet milestones without any problem. There is talk that the company may be able to move up the time line for submission of 510k. FDA under Trump definitely favors Titan. Don't worry about the stock price for the next few weeks definitely will jump with the next milestone update.
The last rise of price was tied to the placement of the robots at centers to start the pre fda process. That news was definitely the cause of price appreciation and well deserved since nothing had been happening for years and the price had fell from $2 to ten cents.
The dilution was needed to get money to pay vendors and advance the companies ability to get to fda submission.
The people on this board who think that raising money is bad, just do not understand companies that are in the development stage. Without money the company is finished. I would say that the key to price appreciation after a raise is how management utilizes the funds and reaches goals quickly and efficiently. If well done the company can raise more money to finish the development and get to actual production.
Good or bad news always leaks ahead of the release, with this price movement and volume, the news will be positive and the stock will be in the 40's by the end of next week.
After reading the review of the system I would have thought that the physician consultants would have advised the company that the CIT has to have a valve so the pneumo does not empty on insertion. Hopefully most of the concerns can be remedied over the next 3-6 months and wont delay fda submission.
McNally should address the short comings of the system and give us an update on the time line. Call it a state to the Sport Address.
That is his incentive to get the price above 56 cents canadian.
Profit...
macnally does not have to buy shares he gets them as compensation. He has incentive to get to fda submission so his shares gain value.
I think that we will see fda submission before any RS and uplisting to the nasdaq because this would help institutional investors support client purchases to avoid price depreciation and shorting of the stock.
The problem with trying to time otc stocks is that news moves them quickly and the easy money is lost.
Not very worried about missing out on returns elsewhere otherwise would never be in this type of stock to begin with. This is a 10-12 times multiple or zero. Nothing in between. Lets hope the former.
News was expected, need to have update on how Titan is ahead of schedule for FDA submission. This company is not very well known so need PR quite a few months prior to FDA to get price up prior to listing on the nasdaq.
Here is something of a holiday gift. What if because of the early installation of all of the systems,and with increased investment, the timeline for when the animal data moved up lets say 3 months, therefore FDA submission moves up and the funding that exists gets us to FDA approval.
No need for further dilution. Just saying.
If you have sold stocks this year and have made money it is worth selling all of the shares that you bought at a high price and take the loss against the gains because this year you will be taxed at a higher rate. If not long term capital gains.
If you have no gains to offset loses than you would want to keep those high cost shares to offset gains from share of titan that you bought recently if the stock in the next few years goes up.
I wanted to see how the stock was being traded with the market makers so I put an ask at 31 cents for 100000 shares this morning at 8:30 am. It is interesting how the time of the placement of the ask on level two changed as the day went on to make it look like it was more recent and they sell small amounts of stock at a lower bid price near the end of the day to try to get sellers to change their ask price.
Need some news next year to bring in more buyers. The first quarter of 2018 will be interesting.
There is a pretty strong support at the .29 to .31 cents range. As the price has approached .30 cents there has been good volume. Also the volume of shares sold below .30 really drops forcing those who want large lots to increase bid.
Like everyone knows if one could predict the future wouldn't be on this message board. Would be on my private island with no internet to annoy me.
The only news over the next two months will be about doctors experience with the robot which since put out by Titan will always be positive. The important news for investors will be fda submission and approval and when we will uplist to the nasdaq so can get institutional investors to bring clients onboard. Figure that news will get us to 75 cents to one dollar. Will creep up a little as that milestone approaches.
Just some fun insight into ethicon and titan. When I first invested in titan 4 yrs ago the main reason was because I thought Ethicon was going to buy this company. I live 2 miles from a ethicon facility in NJ and my neighbor works for J&J. At that time she said that J&J would only buy a company once the product was FDA approved and that the market was proven. So when the sport robot went no where for the past few years that never happened. I would think that ethicon once again is going to take a look at this platform to get into the robotic business because they need to continue to have growth in the endosurgical device area. They just bought a private company earlier this year torax medical that makes an anti-reflux device called linx that can be placed with sport very easily. You never know?
320,000,000@0.31. Gives you 100 million valuation
129,000,000 outstanding warrants and options at there respective values.
Share appreciation should get to 1 dollar around fda approval. Not bad if you can triple your investment in less than a year for people either investing now or those who have averaged pps down by buying when stock less than 20 cents.
Valuation pretty good for a company that has been around a decade and hasn’t had one product even submitted to fda. You know the tech must be decent for new investors to come on board.
This stock needs to be uplisted to the nasdaq to get momentum. Only people buying are people in healthcare and family. Maybe second quarter of next year.
Doesn't really matter at this point the shares were bought at 0.39 US and the price is .28, nobody is going to be selling those shares for a while.
The stock price is a reflection of shareholders selling shares for a loss at the end of the year to take advantage of new tax law changes. Move your profit to lower tax rates.
Since Sept there has only been positive events, placement of units to resume animal data, monies to pay for getting to fda submission, and positive feedback from surgeons.
Prior to the third quarter of this year, I was 95 percent convinced that my investment would be lost, now I am 95 percent convinced that I will at least make a profit.
Remember if you buy and sell within 30 days before or after a trade in same stock can not take the loss immediately from 2017 taxes.
No more raises this year especially with pps going down. Lucky he got 39 cents US per share locked in this year. The value of the share price plus warrant is already lost with the decrease in pps the past few weeks.
Will wait until pps goes below 25 cents to buy more. There will be a lot of pressure on the pps share with people who want to take a loss this year. Lots of shares bought above a dollar over the years. Myself included.
For non medical use sure.
I doubt that is correct because you can not offer a product for sale until fda approval. People can say after seeing the robot I would Like to have one of those but the company can not offer anything for sale until approved.
There is a bunch of new sedar listings dated November 30th and one dated this morning. Are they just the final documents from the last raise?
Agree I will be taking a loss on this stock this year when my tax rate will be higher. After the new tax law my rate will drop therefore off setting gains with stock I bought four years ago when titan was 2 dollars. Be careful with the 30 day rule when buying and selling stocks to off set gains.
Would not worry this is a relatively unknown stock that relies heavily on a small group of investors. Even a million shares is only 300000 $ traded. The daily moves are not a worry. The uplisting of the stock is very important and will occur around the time of fda submission next year. Come back next September and you be happy with the stock price.
The way to play any high risk tech stock is pick a percentage profit and get out when you reach your goal. There is no way any of us can know the future of medicine and the amount of resources that hospitals will have to spend. I have seen the best product lose the contract for one dollar per unit. Medicine is not the consumer market place. Be smart with your investment, pigs get slaughtered both in the market and at titan sport animal studies! Just saying..
The main goal that was completed this year was to have a robot that actually works and can perform the animal dissections so that the data sets can be created to submit to the fda in 2018. That is the main reason I started to buy more shares.
There is really no road blocks to submit to the fda when submitting a 510k. It's not like a drug. Many products get 510k approval without much difficulty.
With this product the main driver to share increase is if it actually will be bought by hospitals. And the driver of that is cost and physician interest, and the belief that the hospital can gain market share with the newest and best tech.
Next month hope to see the product in person and reassure my confidence in this investment.
There are certain time constraints to get the animal data complete. Data will be collected from each site to give 3 sets of independent information for submission. Money allows for sites to be set up and funded but will not push time lines up very much. Getting the robots working quickly at each site does start that clock sooner and I think the company is on time with each installation.
Never take money out of 401k unless over 55 yrs to avoid paying penalty
Chris Seibert who came on board with titan from intuitive prior to Mcnally taking over was a marketing and platform sales manager for intuitive and has great experience getting teams into place whether they are employed by titan or contracted. Of course at this time no company would spend dollars on any sales, marketing or installation teams given titan has not even submitted to fda, however that does not mean the connections to the companies and people that would be involved are not being created.
Hopefully my insights help those on the board be more secure with there investment. My career started out as a Chemical engineer many yrs ago and worked as a pacemaker rep in the medical field for years and than went back to medical school to become a surgeon. Have been practicing for over 20 years. I have made some crappy investments in medical start ups and learned from them. Invested in this product after seeing at a Sages meeting because saw the ability of the device to be used within my field. Was becoming disappointed with previous management and stopped investing until new management came on board.
Finally can say that I am seeing progress in the positive direction over the last 5 months and my fellow surgical friends agree and have invested recently.
Happy Thanksgiving